CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

160 hedge funds and large institutions have $2.3B invested in Celldex Therapeutics in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+29
Holders Change %
+22.14%
% of All Funds
2.81%
Holding in Top 10
11
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+120%
% of All Funds
0.19%
New
44
Increased
53
Reduced
46
Closed
14
Calls
$85.9M
Puts
$69.9M
Net Calls
+$16M
Net Calls Change
+$22.1M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$303M
2
RCM
2
RA Capital Management
Massachusetts
$86.4M
3
Viking Global Investors
3
Viking Global Investors
Connecticut
$41.2M
4
CAC
4
Cowen and Company
New York
$35.1M
5
FAM
5
Fred Alger Management
New York
$28.4M

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$60.9M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$51.3M
3
ACP
3
Acuta Capital Partners
California
$18.2M
4
VC
4
Vivo Capital
California
$26.2M
5
PA
5
Perceptive Advisors
New York
$21.3M
Name Holding Trade Value Shares
Change 		Shares
Change %
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$19.4M -$42.7K -790 -0.2%
ACP
27
Acuta Capital Partners
California
$18.2M -$35.1M -649,906 -66%
Charles Schwab
28
Charles Schwab
California
$17.4M +$12.1M +224,831 +230%
Goldman Sachs
29
Goldman Sachs
New York
$16.6M -$1.64M -30,376 -9%
TCMG
30
TSP Capital Management Group
New Jersey
$14.7M -$11.4M – –
IC
31
Ikarian Capital
Texas
$14.6M -$5.13M -95,113 -26%
GTC
32
Ghost Tree Capital
New York
$13.8M -$1.62M -30,000 -11%
CC
33
Commodore Capital
New York
$13.4M -$4.06M -75,230 -23%
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$11.4M +$10.6M +196,264 +1,292%
ACM
35
Altium Capital Management
New York
$9.99M +$4.96M +91,884 +99%
CS
36
Candriam SCA
Luxembourg
$9.73M -$11.8M -219,463 -55%
Morgan Stanley
37
Morgan Stanley
New York
$9.58M +$2.94M +54,377 +44%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$9.33M +$3.04M +56,311 +48%
Axa
39
Axa
France
$8.8M -$3.56M -65,968 -29%
Renaissance Technologies
40
Renaissance Technologies
New York
$8.71M -$10.9M -202,751 -56%
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
$8.31M +$2.57M +47,512 +45%
Nuveen Asset Management
42
Nuveen Asset Management
Illinois
$8.02M +$297K +5,457 +4%
SI
43
Sofinnova Investments
California
$7.4M +$125K +2,308 +2%
SFM
44
Sphera Funds Management
Israel
$7.04M +$7.04M +130,330 New
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$6.15M +$4.52M +83,625 +276%
Citigroup
46
Citigroup
New York
$5.9M -$591K -10,945 -9%
Voloridge Investment Management
47
Voloridge Investment Management
Florida
$5.52M +$5.52M +102,146 New
EGI
48
EAM Global Investors
California
$5.21M +$1.37M +25,290 +36%
Principal Financial Group
49
Principal Financial Group
Iowa
$5.04M +$516K +9,563 +11%
EI
50
EAM Investors
California
$4.67M +$1.94M +35,866 +71%
1
2
3 4 5